Zepp Health Co. (NYSE:ZEPP) Short Interest Down 46.3% in March

Zepp Health Co. (NYSE:ZEPP) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,200 shares, a decrease of 46.3% from the February 29th total of 4,100 shares. Based on an average daily trading volume, of 72,400 shares, the days-to-cover ratio is currently 0.0 days.

Zepp Health Trading Up 1.0 %

Zepp Health stock traded up $0.01 during trading hours on Thursday, reaching $1.04. The company had a trading volume of 20,618 shares, compared to its average volume of 73,116. The company has a 50-day moving average price of $1.23 and a 200 day moving average price of $1.27. Zepp Health has a 12-month low of $0.90 and a 12-month high of $2.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.04 and a quick ratio of 1.49. The firm has a market cap of $63.79 million, a price-to-earnings ratio of -2.00 and a beta of 0.81.

Analyst Ratings Changes

Separately, Fundamental Research set a $4.96 price target on shares of Zepp Health and gave the company a “buy” rating in a research report on Tuesday.

Institutional Trading of Zepp Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ZEPP. Envestnet Asset Management Inc. bought a new stake in Zepp Health during the 1st quarter valued at approximately $49,000. BlackRock Inc. raised its stake in Zepp Health by 1.2% during the first quarter. BlackRock Inc. now owns 612,416 shares of the company’s stock valued at $1,764,000 after buying an additional 7,427 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Zepp Health by 25.0% in the first quarter. Dimensional Fund Advisors LP now owns 189,774 shares of the company’s stock worth $547,000 after buying an additional 37,952 shares during the last quarter. Renaissance Technologies LLC bought a new position in Zepp Health in the 1st quarter valued at approximately $107,000. Finally, Invesco Ltd. raised its position in Zepp Health by 58.9% in the 1st quarter. Invesco Ltd. now owns 43,383 shares of the company’s stock worth $125,000 after buying an additional 16,087 shares during the last quarter. Hedge funds and other institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.